Search alternatives:
point decrease » point increase (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
e mean » _ mean (Expand Search), a mean (Expand Search), i mean (Expand Search)
point decrease » point increase (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
e mean » _ mean (Expand Search), a mean (Expand Search), i mean (Expand Search)
-
8561
-
8562
-
8563
-
8564
-
8565
-
8566
-
8567
-
8568
Mutant mice exhibited decreased mechanically-evoked action potential firing.
Published 2016“…Data reported as mean ± s.e.m.</p>…”
-
8569
Identification of a Hydroxypyrimidinone Compound (<b>21</b>) as a Potent APJ Receptor Agonist for the Potential Treatment of Heart Failure
Published 2021“…Due to the increased polarity at C2, the permeability for these compounds decreased. Further adjustment of the polarity by replacing the N1 2,6-dimethoxyphenyl group with a 2,6-diethylphenyl group and reoptimization for the potency of the C5 pyrroloamides resulted in potent compounds with improved permeability. …”
-
8570
Identification of a Hydroxypyrimidinone Compound (<b>21</b>) as a Potent APJ Receptor Agonist for the Potential Treatment of Heart Failure
Published 2021“…Due to the increased polarity at C2, the permeability for these compounds decreased. Further adjustment of the polarity by replacing the N1 2,6-dimethoxyphenyl group with a 2,6-diethylphenyl group and reoptimization for the potency of the C5 pyrroloamides resulted in potent compounds with improved permeability. …”
-
8571
Identification of a Hydroxypyrimidinone Compound (<b>21</b>) as a Potent APJ Receptor Agonist for the Potential Treatment of Heart Failure
Published 2021“…Due to the increased polarity at C2, the permeability for these compounds decreased. Further adjustment of the polarity by replacing the N1 2,6-dimethoxyphenyl group with a 2,6-diethylphenyl group and reoptimization for the potency of the C5 pyrroloamides resulted in potent compounds with improved permeability. …”
-
8572
-
8573
N100 amplitude decrease during 1 Hz-rTMS.
Published 2013“…Electrodes C3, CP3’ and CP5’ were pooled. <i>Left</i>: TMS-evoked N100 amplitude continuously decreased during the stimuli 1–500. …”
-
8574
-
8575
Bufalin downregulates SRC–3 and decreases cell viability in TNBC cells.
Published 2015“…(B) Western blotting shows a dose-dependent downregulation of SRC–3 by bufalin and phospho-bufalin in LM3-3 cells. (C-H) Bufalin decrease cell viability of TNBC cells including HCC1143 (C), SUM149PT (D), SUM159PT (E), MDA-MB–231 (F) and MDA-MB-231-LM3-3 (G), but not in primary mouse hepatocytes (H). …”
-
8576
-
8577
-
8578
-
8579
-
8580